Common name
(3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol
IUPAC name
(3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol
SMILES
C(O)C1OCC(C1)O
Common name
(3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol
IUPAC name
(3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol
SMILES
C(O)C1OCC(C1)O
INCHI
InChI=1S/C5H10O3/c6-2-5-1-4(7)3-8-5/h4-7H,1-3H2/t4-,5+/m1/s1
FORMULA
C5H10O3
Common name
(3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol
IUPAC name
(3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol
Molecular weight
118.131
clogP
0.099
clogS
0.528
Frequency
0.0010
HBond Acceptor
3
HBond Donor
2
Total PolarSurface Area
49.69
Number of Rings
1
Rotatable Bond
1
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00327 | Framycetin |
|
Anti-Bacterial Agents; Aminoglycosides; Antibiotics; Respiratory System; Ophthalmologicals; Sensory Organs; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Dermatologicals; Nasal Preparations; Antiinfectives; Medicated Dressings With Antiinfectives; Medicated Dressings; Aminoglycoside Antibacterials; | For the treatment of bacterial blepharitis, bacterial bonjunctivitis, corneal injuries, corneal ulcers and meibomianitis. For the prophylaxis of ocular infections following foreign body removal. |
| FDBD00848 | Neomycin |
|
Anti-Bacterial Agents; Protein Synthesis Inhibitors; Aminoglycosides; Antibiotics; Blood and Blood Forming Organs; Respiratory System; Ophthalmologicals; Sensory Organs; Throat Preparations; Genito Urinary System and Sex Hormones; Alimentary Tract and Metabolism; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Stomatological Preparations; Dermatologicals; Blood Substitutes and Perfusion Solutions; Irrigating Solutions; Antiinfectives; Antibacterials for Intramammary Use; Antidiarrheals, Intestinal Anti-Inflammatory/antiinfective Agents; Antiinfectives and Antiseptics for Local Oral Treatment; Otologicals; Antibiotics for Topical Use; Antiinfectives and Antiseptics for Intrauterine Use; Ophthalmological and Otological Preparations; Aminoglycoside Antibacterials; Intestinal Antiinfectives; | Topical uses include treatment for superficial eye infections caused by susceptible bacteria (used in combination with other antiinfectives), treatment of otitis externa caused by susceptible bacteria, treatment or prevention of bacterial infections in skin lesions, and use as a continuous short-term irrigant or rinse to prevent bacteriuria and gram negative rod bacteremia in abacteriuric patients with indwelling catheters. May be used orally to treat hepatic encephalopathy, as a perioperative prophylactic agent, and as an adjunct to fluid and electrolyte replacement in the treatment of diarrhea caused to enteropathogenic E. coli (EPEC). |
| FDBD01196 | Paromomycin |
|
Anti-Bacterial Agents; Amebicides; Antibiotics; Alimentary Tract and Metabolism; Antidiarrheals, Intestinal Anti-Inflammatory/antiinfective Agents; Intestinal Antiinfectives; | For the treatment of acute and chronic intestinal amebiasis (it is not effective in extraintestinal amebiasis). Also for the management of hepatic coma as adjunctive therapy. |
3 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 4rrr_ligand_1_4.mol2 | 4rrr | 1 | -5.90 | C1[C@@H](C[C@H](O1)CO)O | 8 |
| 4rrq_ligand_1_0.mol2 | 4rrq | 1 | -5.84 | [C@@H]1(OC[C@@H](C1)O)CO | 8 |
| 4rr6_ligand_1_0.mol2 | 4rr6 | 1 | -5.80 | C(O)[C@H]1OC[C@@H](C1)O | 8 |
| 1vkj_ligand_2_9.mol2 | 1vkj | 1 | -5.78 | OC[C@H]1OC[C@@H](C1)O | 8 |
| 4rrf_ligand_1_0.mol2 | 4rrf | 1 | -5.78 | C(O)[C@H]1OC[C@@H](C1)O | 8 |
| 4rra_ligand_1_4.mol2 | 4rra | 1 | -5.76 | C(O)[C@@H]1C[C@H](CO1)O | 8 |
135 ,
14
